You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCR3 inhibition

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • MSS
  • Heidelberg, Germany
    National Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022

Abdominal Aortic Aneurysm (AAA), No Abdominal Aortic Aneurysm (Non-AAA) Trial in Saint Louis (AAA Group (Aim 3A), Non-AAA Group,

Recruiting
  • Abdominal Aortic Aneurysm (AAA)
  • No Abdominal Aortic Aneurysm (Non-AAA)
  • AAA Group (Aim 3A)
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 11, 2022

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

Post-Traumatic Headache Trial (Cilostazol, Placebo)

Not yet recruiting
  • Post-Traumatic Headache
  • (no location specified)
Oct 23, 2022

Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)

Recruiting
  • Heart Failure
  • LCZ 696
  • +4 more
  • New Haven, Connecticut
    Yale New Haven Hospital
Dec 27, 2022

Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

Not yet recruiting
  • Breast Cancer
  • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
  • Ottawa, Ontario, Canada
  • +1 more
Jul 22, 2023

Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine

Recruiting
  • Aicardi-Goutières Syndrome
  • Abacavir (ABC)
  • +2 more
  • Edinburgh, United Kingdom
    Yanick Crow
Aug 26, 2022

Hyperglycemia Drug Induced Trial in Durham (REMD-477)

Terminated
  • Hyperglycemia Drug Induced
  • REMD-477
  • Durham, North Carolina
    Duke University Medical Center
Nov 4, 2022

Neat OGTT, OGTT With Added Sucralose, OGTT With Added Lactisole Trial in New Brunswick (TAS1R2/3 agonist or antagoinst admixture

Completed
  • Neat OGTT
  • +2 more
  • TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test
  • New Brunswick, New Jersey
    Rutgers, Department of Nutritional Sciences
Jun 2, 2023

Itch Trial in Aalborg (Emla 1 hour, EMLA 3 hours, Vehicle cream for 1 hour)

Completed
  • Itch
  • Emla 1 hour
  • +4 more
  • Aalborg, Denmark
    Aalborg University
Jan 16, 2023

Spasticity, Muscle, Spinal Cord Injuries Trial in Edmonton (Baclofen)

Withdrawn
  • Spasticity, Muscle
  • Spinal Cord Injuries
  • Edmonton, Alberta, Canada
    524 HMRC, University of Alberta
Mar 29, 2022

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Leukemia, Acute Lymphocytic Trial in Durham (Copanlisib)

Recruiting
  • Leukemia, Acute Lymphocytic
  • Durham, North Carolina
    Duke Cancer Center
Jun 28, 2022

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Dec 20, 2022

Metastatic Breast Cancer Trial in East Melbourne (BYl719)

Completed
  • Metastatic Breast Cancer
  • East Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2022

Muscle Atrophy, Age-Related Sarcopenia Trial in Derby (Rapamune (sirolimus) 1Mg Tablet, Unilateral resistance exercise training)

Recruiting
  • Muscle Atrophy
  • Age-Related Sarcopenia
  • Rapamune (sirolimus) 1Mg Tablet
  • Unilateral resistance exercise training
  • Derby, United Kingdom
    University of Nottingham School of Medicine
Jun 7, 2022

Healthy Trial in Vancouver (Cannabis oil with a high ratio of THC to CBD, Cannabis oil with a high ratio of CBD to THC, Placebo)

Not yet recruiting
  • Healthy
  • Cannabis oil with a high ratio of THC to CBD
  • +2 more
  • Vancouver, British Columbia, Canada
    B.R.A.I.N. Lab, Institute of Mental Health, Faculty of Medicine,
May 2, 2022

Parkinson Disease Trial in Brussels (behavioral, diagnostic test, other)

Recruiting
  • Parkinson Disease
  • Behavioral data
  • +3 more
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 20, 2022

NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated

Recruiting
  • NSCLC Stage IV
  • +3 more
  • Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
  • Montréal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022

Mesothelioma Trial in United Kingdom (Nivolumab, Placebo)

Active, not recruiting
  • Mesothelioma
  • Dundonald, Belfast, United Kingdom
  • +23 more
Nov 16, 2022

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

Breast Cancer Trial in United States (Benralizumab, fulvestrant or AIs) and PI3K inhibition (alpelisib))

Recruiting
  • Breast Cancer
  • Benralizumab
  • fulvestrant or AIs) and PI3K inhibition (alpelisib)
  • Stanford, California
  • +8 more
Aug 1, 2023

Fungal Infection Trial in Groningen (APX001, Itraconazole, Rifampin)

Completed
  • Fungal Infection
  • Groningen, Netherlands
    PRA-EDS
Oct 27, 2021

Healthy Trial in New Haven (Ritlecitinib 50 mg, Ritlecitinib 200 mg)

Completed
  • Healthy
  • Ritlecitinib 50 mg
  • Ritlecitinib 200 mg
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Feb 4, 2022